概括
在Drosophila melanogaster中暴露于Rous-sarcoma病毒增加了致命突变,可见突变,染色体异常和瘤. 需要进一步的研究来确认对染色体膨胀大小的潜在影响.
科学领域:
- * 分子生物学 * 分子生物学
- * 遗传学 在遗传学方面
- * 病毒学 病毒学
背景情况:
- * 罗斯肉瘤病毒 (RSV) 是一种致癌逆转录病毒.
- *了解病毒对宿主基因的影响对于疾病研究至关重要.
研究的目的:
- * 为了研究Drosophila melanogaster中的Rous瘤病毒的突变和致癌潜力.
- * 评估RSV对遗传稳定性和细胞过程的影响.
主要方法:
- * Drosophila melanogaster 被暴露在含有 Rous 肉瘤病毒的介质中.
- * 量化了突变 (致命,可见,染色体),瘤和其他遗传变化的发生率.
- * 进行了染色体膨胀大小的初步分析.
主要成果:
- *观察到致命突变,可见突变,染色体损失和非分裂的显著增加.
- *治疗组中瘤发生率较高.
- *发现了少量的眼睛马赛克和转位.
- *初步数据表明,染色体膨胀大小的减少不显著.
结论:
- * 鲁斯肉瘤病毒在Drosophila中表现出变异性和潜在的致癌作用.
- *RSV可以诱导各种遗传不稳定性,包括染色体异常.
- *需要进一步研究以验证观察到的对染色体膨胀大小和病毒持久性的影响.
相关概念视频
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...


